Lidingö, Sweden

Eamonn Connolly

This inventor holds 22 USPTO granted patents and 7 published patent applications and 1 EPO patent, primarily in Lactic Acid Bacteria. Top assignees: Biogaia Ab, Michigan State University, Biogala Ab. Active years: 2005-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eamonn Connolly. Retrieved from https://idiyas.com/inventor/eamonn-connolly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 86.4


Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Lidingo, SE (2005 - 2019)
  • Lidingö, SE (2008 - 2019)
  • Lindingö, SE (2020)
  • Lindingo, SE (2018 - 2021)

Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Lactic Acid Bacteria
Bone Loss Prevention
Infantile Colic
Dental Caries
Intestinal Motility
Histamine Production
Food Lysine Absorption
Pet Animals
Bacterial Strains
Lactobacillus reuteri
22 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Eamonn Connolly, Pioneering Inventor from Lidingo, SE

Introduction: Eamonn Connolly is a distinguished inventor hailing from Lidingo, SE, with an impressive portfolio of 21 patents to his name. His groundbreaking work in the field of probiotic lactic acid bacteria has revolutionized the treatment and prophylaxis of various inflammatory conditions in mammals.

Latest Patents: Connolly's latest patents showcase his expertise in the production and utilization of bacterial histamine, as well as the selection and deployment of lactic acid bacteria to prevent bone loss in humans. These innovative methods highlight his commitment to improving health outcomes through pioneering science.

Career Highlights: With a rich professional background, Eamonn Connolly has lent his expertise to esteemed organizations such as Biogaia AB and Michigan State University. His tenure at these institutions has been marked by a relentless pursuit of excellence in the realm of microbiology and health sciences.

Collaborations: Throughout his career, Connolly has collaborated closely with esteemed peers such as Bo Mollstam and Wolfgang Kunze, fostering a spirit of innovation and knowledge-sharing within the scientific community. These collaborations have been instrumental in shaping his pioneering research and development efforts.

Conclusion: Eamonn Connolly's trailblazing work in the field of probiotic lactic acid bacteria stands as a testament to his unwavering dedication to advancing scientific knowledge and improving human health. His numerous patents and collaborations underscore his position as a visionary inventor at the forefront of microbiological innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…